Accepted for Publication: August 17, 2022.
Published Online: August 22, 2022. doi:10.1001/jama.2022.15336
Corresponding Author: Angel Desai, MD, MPH, Division of Infectious Diseases, University of California Davis Medical Center, 4150 V St, Sacramento, CA 95816 (andesai@ucdavis.edu).
Author Contributions: Drs Desai and Thompson had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Desai, Thompson, Cohen.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Desai, Thompson, Neumeister, Arutyunova.
Critical revision of the manuscript for important intellectual content: Desai, Thompson, Trigg, Cohen.
Statistical analysis: Thompson.
Administrative, technical, or material support: Thompson, Neumeister, Arutyunova, Trigg, Cohen.
Supervision: Thompson, Trigg, Cohen
Conflict of Interest Disclosures: None reported.
Disclaimer: Dr Desai is an Associate Editor for JAMA Network Open. She had no role in the review of this submission or the decision to accept for publication.
Additional Contributions: We thank Olivia Kasirye, MD, Sacramento County Department of Public Health, and surrounding counties and health departments for their assistance in rapid diagnosis and treatment of our patients. Dr Kasiyre received no compensation.
1.Adler
H , Gould
S , Hine
P ,
et al; NHS England High Consequence Infectious Diseases (Airborne) Network. Clinical features and management of human monkeypox: a retrospective observational study in the UK.
Lancet Infect Dis. 2022;22(8):1153-1162. doi:
10.1016/S1473-3099(22)00228-6PubMedGoogle ScholarCrossref